Research Desk Line-up: CVS Health Post Earnings Coverage
LONDON, UK / ACCESSWIRE / August 18, 2017 /Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for UnitedHealth Group Inc. (NYSE: UNH) ("UnitedHealth"), following which we have published a free report that can be viewed by signing up at http://protraderdaily.com/optin/?symbol=UNH. The Company announced on August 16, 2017, new leadership roles which will become effective from September 01, 2017. For immediate access to our complimentary reports, including today's coverage, register for free now at:
Discover more of our free reports coverage from other companies within the Health Care Plans industry. Pro-TD has currently selected CVS Health Corporation (NYSE: CVS) for due-diligence and potential coverage as the Company announced on August 08, 2017, its financial results for Q2 which ended on June 30, 2017. Tune in to our site to register for a free membership, and be among the early birds that get our report on CVS Health when we publish it.
At Pro-TD, we make it our mission to bring you news that matter about the stock you follow. Today, our research desk covers a blog story on UNH; also brushing on CVS. Go directly to your stock of interest and access today's free coverage at:
David S. Wichmann, who has been serving as the President of UnitedHealth, will succeed Stephen J. Hemsley as the Chief Executive Officer (CEO) and become a Director of the Company. At the same time, Stephen Hemsley will assume the newly created role of Executive Chairman of the Board of Directors. Also, the current Board Chairman, Richard Burke, will become Lead Independent Director.
Towards Sustainable Growth
The changes in leadership roles are designed to ensure continuity as the Company continues to grow and evolve in the changing health care landscape. UnitedHealth Group will continue on its strategic path to improve health care quality for its customers and care providers. The Company's commitment to high performance and value in health care will drive sustainable growth in 2017, 2018, and beyond.
About David Wichmann, the New CEO
- David Wichmann, aged 54, joined UnitedHealth in 1998 and has developed deep experience across UnitedHealth's businesses. Since then, he has served in various roles with the Company, including the Chief Financial Officer (CFO) from 2011 until mid-2016. He has been serving as the President of UnitedHealth and has overseen UnitedHealthcare, the Company's benefits business, since 2014.
- In addition, he has directed UnitedHealth's enterprise-wide operations and technology efforts and has led external development, M&A, and integration activities at the Company, evaluating important acquisitions and prospects, and building partnerships within and outside the Company. David has also been the key driving force behind the Company's successful innovation and diversification efforts.
- Currently, he leads UnitedHealth's activities in Brazil, among other global markets, which are important for building out the "third leg" of UnitedHealth's long-term growth strategy.
- Above all, he is a champion of UnitedHealth's culture, mission, and values of integrity, compassion, innovation, relationships, and performance. All these put together make him a good fit to become the new CEO of the UnitedHealth.
With regard to his appointment, David Wichmann said that it is a distinct yet humbling honor to guide this enterprise, with its extraordinary people, purpose, and capabilities. He said that he is fortunate to have an exceptional organization, a deep and talented leadership team, and highly dedicated people. He also expressed his gratitude towards the continuous support from Stephen Hemsley, Richard Burke, the Board, the Vice Chairman Larry Renfro, and the entire senior leadership team. He stated that the Company continues to execute on its mission to better serve its customers, shareholders, and all other participants in the health care system. He also said that the health care industry would continue to change and that UnitedHealth is an enterprise built for change as it is innovative, adaptable as well as consumer-centric.
Encouraging Comments from Hemsley
Stephen J. Hemsley, aged 65, announced that this is the appropriate time for a transition in UnitedHealth's management as the Company is performing strongly and has a positive outlook for the foreseeable future. He re-affirmed that David Wichmann is the right choice to succeed as CEO for that future. David has had approximately 20 years of service in UnitedHealth, during which he has acquired the business and leadership skills, enterprise knowledge and support, broad health care experience, and deep expertise in areas that are critical to the Company's future, particularly in growth-oriented technology, operations, and global markets.
He believes that David Wichmann is the appropriate person to lead UnitedHealth through the continuing evolution of health care. Besides, he also mentioned that he looks forward to continuing to help drive the mission, growth, quality, performance, and development of UnitedHealth in his new role.
A Well Thought Decision for UnitedHealth
Richard Burke, the current Board Chairman, who will now become the Lead Independent Director, cited that stability, innovation, and growth have been the hallmarks of the Company over its history. He conveyed that the leadership changes have been the culmination of around four years of discussion, careful planning, leadership development, and execution. David Wichmann was one of Stephen Hemsley's first hires at the Company and had been preparing for the CEO role for many years.
At the same time, Stephen Hemsley will have significant responsibilities as the Executive Chairman, and will be fully engaged in the Company's ongoing affairs and long-term direction going forward. The Company expects that these changes will maximize the contributions of Stephen Hemsley, David Wichmann, the Board, and UnitedHealth's senior management team considerably into the future.
Move praised by Wall Street's Analysts
Wall Street's analysts acclaimed the leadership transition announced by UnitedHealth. Mizuho analyst, Sheryl Skolnick, especially lauded that the fact that Stephen Hemsley was staying in a very important operating, as well as strategic role. He said that Stephen Hemsley was the most visionary health care executive and a superb operator. He also mentioned that David Wichmann taking over as CEO was crucial, as he had taken care of practically every acquisition over the last 20 years. Thus, he is well aware of where the jewels are hidden in the organization, and best knows how to run the still-important health plan. He also said that the changes came in sooner than expected but Stephen Hemsley's continued involvement will ease the transition.
About UnitedHealth Group
UnitedHealth Group (NYSE: UNH) is a diversified health and well-being Company, which is working towards helping people live healthier lives and making the health system work better for everyone. The Company offers a broad spectrum of products and services through two distinct platforms: UnitedHealthcare - which provides health care coverage and benefits services; and Optum - which provides information- and technology-enabled health services.
Last Close Stock Review
UnitedHealth's share price finished yesterday's trading session at $192.70, slightly down 0.55%. A total volume of 2.37 million shares have exchanged hands. The Company's stock price soared 12.39% in the last three months, 17.75% in the past six months, and 35.98% in the previous twelve months. Additionally, the stock surged 20.41% since the start of the year. Shares of the Company have a PE ratio of 23.17 and have a dividend yield of 1.56%. The stock currently has a market cap of $185.88 billion.
Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email email@example.com. Rohit Tuli, a CFA® charter holder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
PRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://protraderdaily.com/disclaimer/.
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: (917) 341.4653
Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
© 2017 Accesswire. All Rights Reserved.